These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31354345)

  • 1. Prognostic value of pretreatment neutrophil count in metastatic renal cell carcinoma: a systematic review and meta-analysis.
    Shen J; Chen Z; Fan M; Lu H; Zhuang Q; He X
    Cancer Manag Res; 2019; 11():5365-5374. PubMed ID: 31354345
    [No Abstract]   [Full Text] [Related]  

  • 2. Meta-analysis of the efficacy of the pretreatment neutrophil-to-lymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors.
    Na N; Yao J; Cheng C; Huang Z; Hong L; Li H; Qiu J
    Oncotarget; 2016 Jul; 7(28):44039-44046. PubMed ID: 27270655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
    Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
    Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.
    Mei Z; Shi L; Wang B; Yang J; Xiao Z; Du P; Wang Q; Yang W
    Cancer Treat Rev; 2017 Jul; 58():1-13. PubMed ID: 28602879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: a systematic review and meta-analysis.
    Xu Y; Zhang Y; Wang X; Kang J; Liu X
    BMC Cancer; 2019 Feb; 19(1):168. PubMed ID: 30795756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.
    Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K
    Oncology; 2019; 97(1):7-17. PubMed ID: 31048577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in melanoma patients: A meta-analysis.
    Zhan H; Ma JY; Jian QC
    Clin Chim Acta; 2018 Sep; 484():136-140. PubMed ID: 29856976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
    Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
    Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis.
    Lu Y; Jiang J; Ren C
    PLoS One; 2020; 15(4):e0230979. PubMed ID: 32241019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with metastatic renal cell carcinoma receiving targeted therapy.
    Zhang GM; Zhu Y; Gu WJ; Zhang HL; Shi GH; Ye DW
    Int J Clin Oncol; 2016 Apr; 21(2):373-378. PubMed ID: 26335242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of systemic immune-inflammation index in patients with metastatic renal cell carcinoma treated with systemic therapy: a meta-analysis.
    Xu J; Chen P; Cao S; Hu X; Li X
    Front Oncol; 2024; 14():1404753. PubMed ID: 38962274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension as a prognostic factor in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis.
    Liu Y; Zhou L; Chen Y; Liao B; Ye D; Wang K; Li H
    BMC Urol; 2019 Jun; 19(1):49. PubMed ID: 31174518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of pretreatment lactate dehydrogenase in patients with metastatic renal cell carcinoma: A systematic review and meta-analysis.
    Zhang N; Zhang H; Zhu D; JiRiGaLa ; Yu D; Wang C; WuYunBiLiGe ; Amin ; ZhiHong ; Yu H; Chen X; Wang M
    Int J Surg; 2020 Jul; 79():66-73. PubMed ID: 32417461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
    Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
    Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.
    de Velasco G; Culhane AC; Fay AP; Hakimi AA; Voss MH; Tannir NM; Tamboli P; Appleman LJ; Bellmunt J; Kimryn Rathmell W; Albiges L; Hsieh JJ; Heng DY; Signoretti S; Choueiri TK
    Oncologist; 2017 Mar; 22(3):286-292. PubMed ID: 28220024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Sarcomatoid Differentiation in Patients With Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Zhi H; Feng M; Liu S; Na T; Zhang N; BiLiGe W
    Front Oncol; 2020; 10():591001. PubMed ID: 33134181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients.
    Yu Y; Qian L; Cui J
    Mol Clin Oncol; 2017 Sep; 7(3):498-506. PubMed ID: 28811903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative apolipoprotein B/A1 ratio is an independent prognostic factor in metastatic renal cell carcinoma.
    Zhang F; Xie Y; Ma X; Gu L; Li H; Li X; Guo G; Zhang X
    Urol Oncol; 2019 Mar; 37(3):184.e9-184.e17. PubMed ID: 30509867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.
    Yang Z; Gu JH; Guo CS; Li XH; Yang WC
    Oncotarget; 2017 Jul; 8(28):46414-46424. PubMed ID: 28423365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis.
    Gu XB; Tian T; Tian XJ; Zhang XJ
    Sci Rep; 2015 Jul; 5():12493. PubMed ID: 26205001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.